NCT00195598已完成3 期
Pilot Study of Venlafaxine Extended Release (XR) in the Treatment of Panic Disorder (PD) in Comparison to Paroxetine.
Wyeth is now a wholly owned subsidiary of Pfizer4 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2005年1月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
- 试验地点
- 4
- 主要终点
- To evaluate the improvement of social function following therapy with Venlafaxine extended release (XR)in the Treatment of Panic Disorder in comparison to Paroxetine.
研究概览
简要总结
The purpose of this pilot study is to evaluate the improvement in social function following therapy with venlafaxine extended release (XR) in the treatment of panic disorder (PD) in comparison to paroxetine. An additional purpose of this pilot study is to obtain the tolerability of using venlafaxine extended release (XR) in the treatment of panic disorder (PD) in comparison to paroxetine.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Meet DSM IV criteria for Panic Disorder (with or without agoraphobia) for at least 3 months before study day
- •Have a minimum of 8 full-symptom panic attacks during the 4 weeks before the screening visit.
- •Provide a written informed consent
排除标准
- •Treatment with Venlafaxine within 6 months of study day 1, as well Paroxetine
- •Known hypersensitivity to Venlafaxine or related compounds as well to Paroxetine.
- •Psychopharmacologic drugs within 14 days of study day 1
结局指标
主要结局
To evaluate the improvement of social function following therapy with Venlafaxine extended release (XR)in the Treatment of Panic Disorder in comparison to Paroxetine.
次要结局
- Obtain the tolerability of using Venlafaxine extended release (XR) in the treatment of Panic Disorder in comparison to Paroxetine.
研究者
研究点 (4)
Loading locations...
相似试验
已完成
4 期
Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious PatientsAnxiety DisordersDepressionNCT00546923Wyeth is now a wholly owned subsidiary of Pfizer210
已完成
3 期
Study Evaluating Venlafaxine ER in Patients With Panic DisorderPanic DisorderNCT00044772Wyeth is now a wholly owned subsidiary of Pfizer653
已完成
4 期
Study Evaluating Venlafaxine ER in Recurrent DepressionDepressive Disorder, MajorRecurrenceNCT00046020Wyeth is now a wholly owned subsidiary of Pfizer1,096
已完成
2 期
Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in AdultsMajor Depressive DisorderNCT00839423H. Lundbeck A/S426
已完成
4 期
Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining RemissionDepressionNCT00546494Wyeth is now a wholly owned subsidiary of Pfizer350